LTBP2 and familial dilated cardiomyopathy: Further supporting evidence for the role of LTBP2 in promoting a dilated phenotype was recently highlighted by Pang et al. in a doxorubicin-induced rat model of DCM, wherein myocardial expression was significantly upregulated.